Dr. Mariana Socal, MD, PhD is an associate professor of Health Policy and Management at the Johns Hopkins Bloomberg School of Public Health. Prof. Socal holds a joint faculty appointment at the Johns Hopkins Carey Business School.
Prof. Socal researches ways to improve access and affordability of prescription drugs. Specific topics include the global pharmaceutical supply chain, gene therapies, generics and biosimilar markets, and ways to control spending without restricting access to prescription drugs.
Dr. Socal has authored over 100 peer-reviewed studies and has frequent engagements in printed media, radio, and TV.
Dr. Socal routinely advises states, Congress, and the US government on biopharmaceutical pricing, regulation and supply chains, having provided testimony before the US Congress, the FDA, and various states on such issues.
Dr. Socal serves as member of the National Academies of Science, Engineering, and Medicine Standing Committee on Emerging Infectious Diseases and 21st Century Health Threats and the World Health Organization Technical Advisory Group on Pricing Policies for Medicines.
Dr. Socal is a physician trained in adult neurology. She holds a master’s in public policy from Princeton University and a PhD in Public Health/Health Systems from Johns Hopkins University.
